507 related articles for article (PubMed ID: 19227009)
1. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin: a potential chemopreventive agent in bladder cancer.
Kamat AM; Nelkin GM
Urology; 2005 Dec; 66(6):1209-12. PubMed ID: 16360444
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and antioxidant activity of Polyalthia longifolia stem bark ethanol extract.
Manjula SN; Kenganora M; Parihar VK; Kumar S; Nayak PG; Kumar N; Ranganath Pai KS; Rao CM
Pharm Biol; 2010 Jun; 48(6):690-6. PubMed ID: 20645743
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.
Bösel J; Gandor F; Harms C; Synowitz M; Harms U; Djoufack PC; Megow D; Dirnagl U; Hörtnagl H; Fink KB; Endres M
J Neurochem; 2005 Mar; 92(6):1386-98. PubMed ID: 15748157
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1.
Araújo FA; Rocha MA; Mendes JB; Andrade SP
Biomed Pharmacother; 2010 Jan; 64(1):29-34. PubMed ID: 19811885
[TBL] [Abstract][Full Text] [Related]
12. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
13. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
Uyuklu M; Meiselman HJ; Baskurt OK
Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the methanolic extract of Ammannia baccifera L. against Dalton's ascites lymphoma induced ascitic and solid tumors in mice.
Loganayaki N; Manian S
J Ethnopharmacol; 2012 Jun; 142(1):305-9. PubMed ID: 22613234
[TBL] [Abstract][Full Text] [Related]
15. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
[TBL] [Abstract][Full Text] [Related]
16. Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?
Doyon M; Hale TM; Huot-Marchand JE; Wu R; de Champlain J; DeBlois D
Vascul Pharmacol; 2011; 54(1-2):5-12. PubMed ID: 20951229
[TBL] [Abstract][Full Text] [Related]
17. Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation.
Tanaka K; Honda M; Takabatake T
Clin Exp Pharmacol Physiol; 2004; 31(5-6):360-4. PubMed ID: 15191412
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
Bhutia SK; Mallick SK; Maiti S; Maiti TK
Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies.
Yang PM; Liu YL; Lin YC; Shun CT; Wu MS; Chen CC
Cancer Res; 2010 Oct; 70(19):7699-709. PubMed ID: 20876807
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
